Minghui Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Minghui Wang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Baishen Chen
Department of Oncology NanfangHospital Southern Medical University Guangzhou China
1 shared publicationDuoguang Wu
Department of Oncology NanfangHospital Southern Medical University Guangzhou China
1 shared publicationFei Cui
Department of Oncology NanfangHospital Southern Medical University Guangzhou China
1 shared publicationWenjian Wang
Department of Oncology NanfangHospital Southern Medical University Guangzhou China
1 shared publicationXiaotian He
Department of Oncology NanfangHospital Southern Medical University Guangzhou China
1 shared publication
Latest Publications
- 28 June 2016
- Published by Wiley in Cell Proliferation
- Vol. 49 (4) , 476-483
Hypoxia‐induced microRNA‐301b regulates apoptosis by targeting Bim in lung cancer
Objectives: Worldwide, lung cancer accounts for the majority of cancer‐related deaths. Aberrant expression of mi RNA s has increasingly been reported to be associated with tumour progression. This study aimed to explore the role of miR‐301b in regulating apoptosis in lung cancer. Materials and methods: Expression of miR‐301b was assessed by real‐time PCR in cell lines, human patient tissues and cells treated under hypoxia and DMOG . Scramble si RNA , miR‐301b inhibitor and miR‐301b mimics were transfected into lung cancer cells to determine their effects on apoptosis. Additionally, a mouse xenograft model was used to explore functions of miR‐301b on apoptosis, in vivo. Finally, relationships between Bim and miR‐301b levels were explored by luciferase reporter assay and Western blotting. Results: We found that miR‐301b was highly expressed in lung cancer tissues and cell lines. Expression of miR‐301b was induced by hypoxia, and miR‐301b suppressed expression of Bim by targeting its 3′UTR. Functionally, ectopic expression of miR‐301b enhanced cell population growth, reduced apoptosis and reduced sensitivity of cells to chemotherapy. In the xenograft model, overexpression of miR‐301b promoted tumour growth. Additionally, miR‐301b and Bim expression were inversely correlated in clinical lung cancer samples. Conclusions: This study provides new insights into the function of mi RNA ‐301b in lung cancer and suggests that mi RNA ‐301b could be a potential molecular target for chemotherapy.
- 28 June 2016
- Published by Wiley in Cell Proliferation
- Vol. 49 (4) , 476-483
Hypoxia‐induced microRNA‐301b regulates apoptosis by targeting Bim in lung cancer
Objectives: Worldwide, lung cancer accounts for the majority of cancer‐related deaths. Aberrant expression of mi RNA s has increasingly been reported to be associated with tumour progression. This study aimed to explore the role of miR‐301b in regulating apoptosis in lung cancer. Materials and methods: Expression of miR‐301b was assessed by real‐time PCR in cell lines, human patient tissues and cells treated under hypoxia and DMOG . Scramble si RNA , miR‐301b inhibitor and miR‐301b mimics were transfected into lung cancer cells to determine their effects on apoptosis. Additionally, a mouse xenograft model was used to explore functions of miR‐301b on apoptosis, in vivo. Finally, relationships between Bim and miR‐301b levels were explored by luciferase reporter assay and Western blotting. Results: We found that miR‐301b was highly expressed in lung cancer tissues and cell lines. Expression of miR‐301b was induced by hypoxia, and miR‐301b suppressed expression of Bim by targeting its 3′UTR. Functionally, ectopic expression of miR‐301b enhanced cell population growth, reduced apoptosis and reduced sensitivity of cells to chemotherapy. In the xenograft model, overexpression of miR‐301b promoted tumour growth. Additionally, miR‐301b and Bim expression were inversely correlated in clinical lung cancer samples. Conclusions: This study provides new insights into the function of mi RNA ‐301b in lung cancer and suggests that mi RNA ‐301b could be a potential molecular target for chemotherapy.